Pulmonary Alveolar Proteinosis

Browse recruiting and upcoming clinical trials for pulmonary alveolar proteinosis.

Patient-friendly, AI-assisted summaries based on official ClinicalTrials.gov ↗ records. Last updated: Oct 10, 2026

About this listHide

ClinicalTrials.gov is the complete and most up-to-date source. Trials may be missing, and trial information may have changed since our last check. Always verify important information in the official registry.

5 trials

Showing 5 trials

Who can join AIPeople with hereditary pulmonary alveolar proteinosis (hPAP).
What is being studied AITests safety, tolerability, and biological and clinical effects of gene-corrected macrophage transplant.
Study typeTreatment (drug) · Phase 1/2
CountriesUnited States
Who can join AIPeople diagnosed with Pulmonary Alveolar Proteinosis (any type); autoimmune PAP patients for the longitudinal portion.
What is being studied AIDBS blood-spot GM-CSF autoantibody testing, genetics, natural history and severity measures for pulmonary alveolar proteinosis.
Study typeRegistry
CountriesUnited States